BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 28478507)

  • 21. TRAF4 Maintains Deubiquitination of Caveolin-1 to Drive Glioblastoma Stemness and Temozolomide Resistance.
    Li Y; Wang T; Wan Q; Wang Q; Chen Z; Gao Y; Ye Y; Lin J; Zhao B; Wang H; Yang J; Zhao K; Lu N
    Cancer Res; 2022 Oct; 82(19):3573-3587. PubMed ID: 35895752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The CHAC1-inhibited Notch3 pathway is involved in temozolomide-induced glioma cytotoxicity.
    Chen PH; Shen WL; Shih CM; Ho KH; Cheng CH; Lin CW; Lee CC; Liu AJ; Chen KC
    Neuropharmacology; 2017 Apr; 116():300-314. PubMed ID: 27986595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glioma initiating cells form a differentiation niche via the induction of extracellular matrices and integrin αV.
    Niibori-Nambu A; Midorikawa U; Mizuguchi S; Hide T; Nagai M; Komohara Y; Nagayama M; Hirayama M; Kobayashi D; Tsubota N; Takezaki T; Makino K; Nakamura H; Takeya M; Kuratsu J; Araki N
    PLoS One; 2013; 8(5):e59558. PubMed ID: 23704872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temozolomide sensitizes stem-like cells of glioma spheres to TRAIL-induced apoptosis via upregulation of casitas B-lineage lymphoma (c-Cbl) protein.
    Zhitao J; Long L; Jia L; Yunchao B; Anhua W
    Tumour Biol; 2015 Dec; 36(12):9621-30. PubMed ID: 26142735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transglutaminase 2 Inhibition Reverses Mesenchymal Transdifferentiation of Glioma Stem Cells by Regulating C/EBPβ Signaling.
    Yin J; Oh YT; Kim JY; Kim SS; Choi E; Kim TH; Hong JH; Chang N; Cho HJ; Sa JK; Kim JC; Kwon HJ; Park S; Lin W; Nakano I; Gwak HS; Yoo H; Lee SH; Lee J; Kim JH; Kim SY; Nam DH; Park MJ; Park JB
    Cancer Res; 2017 Sep; 77(18):4973-4984. PubMed ID: 28754668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TRIM8 regulates stemness in glioblastoma through PIAS3-STAT3.
    Zhang C; Mukherjee S; Tucker-Burden C; Ross JL; Chau MJ; Kong J; Brat DJ
    Mol Oncol; 2017 Mar; 11(3):280-294. PubMed ID: 28100038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oligodendrocyte Progenitor Cells and Macrophages/Microglia Produce Glioma Stem Cell Niches at the Tumor Border.
    Hide T; Komohara Y; Miyasato Y; Nakamura H; Makino K; Takeya M; Kuratsu JI; Mukasa A; Yano S
    EBioMedicine; 2018 Apr; 30():94-104. PubMed ID: 29559295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction Therapy of Retinoic Acid with a Temozolomide-Loaded Gold Nanoparticle-Associated Ultrasound Effect on Glioblastoma Cancer Stem-Like Colonies.
    Fadera S; Chen PY; Liu HL; Lee IC
    ACS Appl Mater Interfaces; 2021 Jul; 13(28):32845-32855. PubMed ID: 34235925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NEO212 Inhibits Migration and Invasion of Glioma Stem Cells.
    Marín-Ramos NI; Thein TZ; Cho HY; Swenson SD; Wang W; Schönthal AH; Chen TC; Hofman FM
    Mol Cancer Ther; 2018 Mar; 17(3):625-637. PubMed ID: 29440289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Xihuang Pill-destabilized CD133/EGFR/Akt/mTOR cascade reduces stemness enrichment of glioblastoma via the down-regulation of SOX2.
    Xu L; Duan H; Zou Y; Wang J; Liu H; Wang W; Zhu X; Chen J; Zhu C; Yin Z; Zhao X; Wang Q
    Phytomedicine; 2023 Jun; 114():154764. PubMed ID: 36963368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dedifferentiation of Glioma Cells to Glioma Stem-like Cells By Therapeutic Stress-induced HIF Signaling in the Recurrent GBM Model.
    Lee G; Auffinger B; Guo D; Hasan T; Deheeger M; Tobias AL; Kim JY; Atashi F; Zhang L; Lesniak MS; James CD; Ahmed AU
    Mol Cancer Ther; 2016 Dec; 15(12):3064-3076. PubMed ID: 27765847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TRPM7 channels regulate glioma stem cell through STAT3 and Notch signaling pathways.
    Liu M; Inoue K; Leng T; Guo S; Xiong ZG
    Cell Signal; 2014 Dec; 26(12):2773-81. PubMed ID: 25192910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel berbamine derivative inhibits cell viability and induces apoptosis in cancer stem-like cells of human glioblastoma, via up-regulation of miRNA-4284 and JNK/AP-1 signaling.
    Yang F; Nam S; Brown CE; Zhao R; Starr R; Ma Y; Xie J; Horne DA; Malkas LH; Jove R; Hickey RJ
    PLoS One; 2014; 9(4):e94443. PubMed ID: 24732116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stemness Marker Detection in the Periphery of Glioblastoma and Ability of Glioblastoma to Generate Glioma Stem Cells: Clinical Correlations.
    Raysi Dehcordi S; Ricci A; Di Vitantonio H; De Paulis D; Luzzi S; Palumbo P; Cinque B; Tempesta D; Coletti G; Cipolloni G; Cifone MG; Galzio R
    World Neurosurg; 2017 Sep; 105():895-905. PubMed ID: 28559081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eukaryotic initiation factor 5B (eIF5B) regulates temozolomide-mediated apoptosis in brain tumour stem cells (BTSCs).
    Ross JA; Ahn BY; King J; Bressler KR; Senger DL; Thakor N
    Biochem Cell Biol; 2020 Dec; 98(6):647-652. PubMed ID: 31671279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
    Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
    Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ABT-888 enhances cytotoxic effects of temozolomide independent of MGMT status in serum free cultured glioma cells.
    Balvers RK; Lamfers ML; Kloezeman JJ; Kleijn A; Berghauser Pont LM; Dirven CM; Leenstra S
    J Transl Med; 2015 Feb; 13():74. PubMed ID: 25886061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dehydroepiandrosterone Induces Temozolomide Resistance Through Modulating Phosphorylation and Acetylation of Sp1 in Glioblastoma.
    Yang WB; Chuang JY; Ko CY; Chang WC; Hsu TI
    Mol Neurobiol; 2019 Apr; 56(4):2301-2313. PubMed ID: 30022431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tanshinone IIA inhibits the growth, attenuates the stemness and induces the apoptosis of human glioma stem cells.
    Yang L; Guo H; Dong L; Wang L; Liu C; Wang X
    Oncol Rep; 2014 Sep; 32(3):1303-11. PubMed ID: 24970314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
    Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
    Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.